Cargando…
Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis
BACKGROUND: Cisplatin resistance is among the main reasons for the poor prognosis of ovarian cancer (OC) patients. Until now, effective biomarkers for predicting cisplatin resistance in OC and specific drugs for reversing this resistance are lacking. This study identified the critical gene associate...
Autores principales: | Zeng, Qingsong, Yi, Cunjian, Lu, Jinzhi, Wang, Xiaowen, Chen, Keming, Hong, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134351/ https://www.ncbi.nlm.nih.gov/pubmed/36708070 http://dx.doi.org/10.1002/cam4.5637 |
Ejemplares similares
-
Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors
por: Cha, Yoon Jin, et al.
Publicado: (2020) -
Expression and significance of transforming growth factor-β1 in epithelial ovarian cancer and its extracellular matrix
por: CHEN, KEMING, et al.
Publicado: (2014) -
EMP1 as a Potential Biomarker in Liver Fibrosis: A Bioinformatics Analysis
por: Chen, Xuchen, et al.
Publicado: (2023) -
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
por: Moghbeli, Meysam
Publicado: (2021) -
Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis
por: Zhang, Xue, et al.
Publicado: (2021)